22.25p+0.00 (+0.00%)16 Aug 2022, 16:30
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

E-Therapeutics PLC Fundamentals

Company NameE-Therapeutics PLCLast Updated2022-08-16
IndustryBiotechnologySectorHealthcare
Shares in Issue514.615 mMarket Cap£114.50 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0231Debt Equity Ratio0.0105
Asset Equity Ratio1.0734Cash Equity Ratio0.9612
Quick Ratio17.9920Current Ratio19.31
Price To Book Value4.0933ROCE0

E-Therapeutics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

E-Therapeutics PLC Company Financials

Assets2022202120202019
Tangible Assets£805,000.00£79,000.00£91,000.00£42,000.00
Intangible Assets£102,000.00£83,000.00£111,000.00£119,000.00
Investments0000
Total Fixed Assets£907,000.00£162,000.00£203,000.00£161,000.00
Stocks0000
Debtors£231,000.00£57,000.00£36,000.00£18,000.00
Cash & Equivalents£26.65 m£13.03 m£3.84 m£5.90 m
Other Assets00£1,000.000
Total Assets£29.76 m£14.31 m£4.79 m£7.51 m
Liabilities2022202120202019
Creditors within 1 year£1.49 m£427,000.00£261,000.00£707,000.00
Creditors after 1 year£295,000.000£23,000.000
Other Liabilities0000
Total Liabilities£1.79 m£427,000.00£284,000.00£707,000.00
Net assets£27.97 m£13.88 m£4.50 m£6.80 m
Equity2022202120202019
Called up share capital£515,000.00£421,000.00£269,000.00£269,000.00
Share Premium£99.24 m£77.67 m£65.18 m£65.17 m
Profit / Loss-£9.52 m-£4.47 m-£2.87 m-£5.08 m
Other Equity£27.97 m£13.88 m£4.50 m£6.80 m
Preference & Minorities0000
Total Capital Employed£27.73 m£13.63 m£4.25 m£6.80 m
Ratios2022202120202019
Debt Ratio£0.010£0.010
Debt-to-Equity£0.010£0.010
Assets / Equity1.07341.07341.07341.0734
Cash / Equity0.96120.96120.96120.9612
EPS-£0.02-£0.01-£0.01-£0.01
Cash Flow2022202120202019
Cash from operating activities-£7.80 m-£3.36 m-£2.03 m-£3.70 m
Cashflow before financing£14.53 m£9.24 m-£2.06 m-£3.69 m
Increase in Cash£4.59 m£4.17 m-£2.06 m-£1.19 m
Income2022202120202019
Turnover£477,000.00£317,000.00£456,000.00£44,000.00
Cost of sales0000
Gross Profit£477,000.00£317,000.00£456,000.00£44,000.00
Operating Profit-£9.57 m-£4.49 m-£2.89 m-£5.11 m
Pre-Tax profit-£9.52 m-£4.47 m-£2.87 m-£5.08 m

E-Therapeutics PLC Company Background

SectorHealthcare
Activitiese-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease.
Latest Interim Date26 Oct 2021
Latest Fiscal Year End Date4 May 2022

E-Therapeutics PLC Directors

AppointedNamePosition
2020-02-11Mr. Iain Gladstone RossNon-Executive Director,Chairman
2020-02-11Ms. Christine Helen SodenNon-Executive Director
2011-08-09Mr. Johnny Mark CordinerExecutive Director,Finance and Commercial Director
2022-07-11Professor Trevor Mervyn Jones CBENon-Executive Director,Chairman
2022-05-04Mr. Michael Anthony BrethertonNon-Executive Director,Interim Chief Financial Officer
2015-05-12Professor Oliver Francis Wintour JamesNon-Executive Director,Chairman
2017-05-08Professor Malcolm Philip YoungExecutive Director,Chief Executive Officer
2011-08-09Dr. Royston Frederick DruckerExecutive Director,Chief Medical Officer
2018-04-04Mr. Bradley Richard HoyNon-Executive Director
2018-04-04Mr. Sean Torquil Nicolson Executive Director,Company Secretary
2018-04-04Mr. Stephen Raymond SelfExecutive Director,Development Director
2014-04-07Mr. Daniel ElgerExecutive Director,Chief Financial Officer
2015-10-29Dr. Rajesh ChopraNon-Executive Director
2022-05-04Mr. Ahmad Ali Mortazavi Executive Director,Chief Executive Officer
2022-05-04Mr. Steven MedlicottExecutive Director,Finance Director and Interim COO
2020-02-11Dr. Raymond John BarlowExecutive Director,Chief Executive Officer

E-Therapeutics PLC Contact Details

Company Namee-Therapeutics PLC
Address17 Blenheim Office Park, Long Hanborough, OX29 8LN
Telephone+44 1993880000
Websitehttps://www.etherapeutics.co.uk

E-Therapeutics PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
SolicitorStephenson Harwood
Phone+44 2073294422
Fax+44 2073297100
StockbrokerNumis Securities Limited
Phone+44 2072601000
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
AuditorDeloitte
Phone+44 2079363000
SolicitorBond Dickinson
Phone+44 3454150000
Fax+44 3454155256
Financial PR AdviserInstinctif Partners
Phone+44 2074572020
Fax+44 2078667900
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132
BankBank of Scotland
AuditorKPMG AUDIT PLC